Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
12
×
life sciences
national blog main
clinical trials
national top stories
new york blog main
new york top stories
fda
boston
drugs
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
onpattro
patisiran
raleigh-durham blog main
raleigh-durham top stories
rna interference
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
allergan
aminolevulinic acid
cancer
europe blog main
What
drug
12
×
medicine
12
×
fda
new
alnylam
approved
rnai
cancer
data
interference
pharmaceuticals
rna
second
disease
market
nasdaq
ok
oks
post
seek
specifically
speedy
weight
aces
afternoon
ago
aldeyra
alkermes
alnylam’s
alzheimer's
announced
antipsychotic
approval
approves
bad
benefits
big
brain
brexanolone
case
Language
unset
Current search:
xconomy.com
×
medicine
×
" boston top stories "
×
drug
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug